Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines
- PMID: 12927638
- DOI: 10.1016/S0304-3959(03)00138-6
Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines
Abstract
Injury to peripheral nerves often produces non-physiological, long-lasting spontaneous pain, hyperalgesia and allodynia that are refractory to standard treatment and often insensitive to opioids, such as morphine. Recent studies demonstrate spinal glial activation and increased proinflammatory cytokines in animal models of neuropathic pain. When these data are considered together, a unifying hypothesis emerges which implicates a role of central neuroimmune processes in the etiology of neuronal and behavioral hypersensitivity. The present investigation assessed the influence of propentofylline, a glial modulating and anti-inflammatory agent, on the development of L5 spinal nerve transection-induced hyperalgesia and associated enhancement of spinal neuroimmune responses using real-time reverse transcription-polymerase chain reaction, RNase protection assay, enzyme-linked immunosorbent assay, and immunocytochemistry in rats. The results show that chronic propentofylline treatment attenuated the development of hyperalgesia and restored the analgesic activity of acute morphine in neuropathic rats. These findings directly correlated with the ability of propentofylline to inhibit glial activation and enhanced spinal proinflammatory cytokines following peripheral nerve injury. These findings along with our earlier observations of an anti-allodynic activity of propentofylline using the identical animal model of mononeuropathy supports the concept that modulation of glial and neuroimmune activation may be potential therapeutic targets to treat or prevent neuropathic pain. Further, restoration of the analgesic activity of morphine by propentofylline treatment suggests that increased glial activity and proinflammatory cytokine responses may account for the decreased analgesic efficacy of morphine observed in the treatment of neuropathic pain.
Similar articles
-
Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats.Neuropsychopharmacology. 2004 Feb;29(2):327-34. doi: 10.1038/sj.npp.1300315. Neuropsychopharmacology. 2004. PMID: 14532913
-
Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury.Brain Behav Immun. 2007 Feb;21(2):238-46. doi: 10.1016/j.bbi.2006.07.001. Epub 2006 Sep 1. Brain Behav Immun. 2007. PMID: 16949251
-
The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats.J Neurosci. 2002 Nov 15;22(22):9980-9. doi: 10.1523/JNEUROSCI.22-22-09980.2002. J Neurosci. 2002. PMID: 12427855 Free PMC article.
-
Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain.Handb Exp Pharmacol. 2011;(200):235-50. doi: 10.1007/978-3-642-13443-2_8. Handb Exp Pharmacol. 2011. PMID: 20859798 Review.
-
Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness.Pharmacol Rep. 2008 May-Jun;60(3):297-307. Pharmacol Rep. 2008. PMID: 18622054 Review.
Cited by
-
P2X3 receptor upregulation in trigeminal ganglion neurons through TNFα production in macrophages contributes to trigeminal neuropathic pain in rats.J Headache Pain. 2021 Apr 26;22(1):31. doi: 10.1186/s10194-021-01244-4. J Headache Pain. 2021. PMID: 33902429 Free PMC article.
-
Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine.J Neurosci. 2013 Oct 2;33(40):15952-63. doi: 10.1523/JNEUROSCI.1609-13.2013. J Neurosci. 2013. PMID: 24089500 Free PMC article.
-
Imaging of neuroinflammation in migraine with aura: A [11C]PBR28 PET/MRI study.Neurology. 2019 Apr 23;92(17):e2038-e2050. doi: 10.1212/WNL.0000000000007371. Epub 2019 Mar 27. Neurology. 2019. PMID: 30918090 Free PMC article.
-
CDMP1 overexpression mediates inflammatory cytokine‑induced apoptosis via inhibiting the Wnt/β‑Catenin pathway in rat dorsal root ganglia neurons.Int J Mol Med. 2018 Sep;42(3):1247-1256. doi: 10.3892/ijmm.2018.3716. Epub 2018 Jun 5. Int J Mol Med. 2018. PMID: 29901085 Free PMC article.
-
Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics.J Neurosci. 2015 Oct 14;35(41):13879-88. doi: 10.1523/JNEUROSCI.2711-15.2015. J Neurosci. 2015. PMID: 26468188 Free PMC article. Review.
References
-
- Andine P, Rudolphi KA, Fredholm BB, Hagberg H. Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia. Br J Pharmacol. 1990;100:814-818.
-
- Bao L, Zhu Y, Elhassan AM, Qinyang W, Xiao B, Zhu J, Lindgren JU. Adjuvant-induced arthritis: IL-1β, IL-6 and TNF-α are up-regulated in the spinal cord. Neuroreport. 2001;12:3905-3908.
-
- Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci. 1998;18:3251-3260.
-
- Bian D, Ossipov MH, Ibrahim M, Raffa RB, Tallarida RJ, Malan TP Jr, Lai J, Porreca F. Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphine antiserum. Brain Res. 1999;831:55-63.
-
- Burgess SE, Gardell LR, Ossipov MH, Malan TP Jr, Vanderah TW, Lai J, Porreca F. Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci. 2002;22:5129-5136.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources